Last edition
News about "innovative therapies"
Laekna's LAE002 Breast Cancer Drug Application Accepted by China's NMPA
Laekna has advanced LAE002 toward potential commercialisation in China after the NMPA accepted its NDA for afuresertib in patients with advanced HR+/HER2- breast cancer.
Innovative Therapies | 12/08/2026 | By News Bureau | 106
Simcere Pharmaceutical and Stanford Medicine Partner on IPF Therapy Research
Simcere Pharmaceutical has entered a research collaboration with Stanford Medicine to develop innovative therapies for Idiopathic Pulmonary Fibrosis (IPF).
Innovative Therapies | 16/06/2026 | By News Bureau | 111
Biocytogen and Sihuan Pharmaceutical Partner to Advance Next-Gen Antibody Therapies
The strategic collaboration between Bioctogen and Sihuan Pharmaceutical combines antibody discovery platforms and manufacturing expertise to accelerate development of innovative treatments, including weight loss therapies.
Innovative Therapies | 06/04/2026 | By News Bureau | 111
Eris Lifesciences Launches Weekly Semaglutide Shot at INR 220 in India
Eris Lifesciences has launched a weekly Semaglutide injection starting at INR 220 per dose and plans to introduce a pen-device version in April, priced between INR 4,000 and INR 4,500 per month to enhance patient convenience and adoption.
Innovative Therapies | 21/03/2026 | By News Bureau | 540
Innovent Biologics and Eli Lilly Forge Strategic Collaboration in Oncology and Immunology
Innovent Biologics will receive USD 350 million upfront and up to USD 8.5 billion in milestones under a new global development pact, with Lilly securing ex-Greater China rights to novel oncology and immunology programmes.
Innovative Therapies | 10/02/2026 | By News Bureau | 172
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy